Acadia Pharmaceuticals reported $117.68M in Current Liabilities for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 117.68M 1.92M
ALKERMES ALKS:US $ 438.52M 23.84M
Alnylam Pharmaceuticals ALNY:US $ 657.68M 51.72M
Aptinyx Inc APTX:US $ 5.68M 945K
Biogen BIIB:US $ 5018M 1071.4M
Biomarin Pharmaceutical BMRN:US $ 464.73M 25.69M
Bristol Myers Squibb BMY:US $ 20915M 1906M
Cara Therapeutics CARA:US $ 21.17M 2.87M
Corcept Therapeutics CORT:US $ 49.06M 8.19M
Cytokinetics CYTK:US $ 66.84M 0M
Eisai 4523:JP Y 301894M 11439M
Eli Lilly And LLY:US $ 15620.6M 2234.6M
Intercept Pharmaceuticals ICPT:US $ 151.43M 0.39M
Intra Cellular Therapies ITCI:US $ 70.63M 11.56M
Marinus Pharmaceuticals MRNS:US $ 23.11M 3.57M
Moderna Inc MRNA:US 6.81B 2.43B
Neurocrine Biosciences NBIX:US $ 285.7M 32.2M
Prothena PRTA:US 40.11M 3.61M
Ptc Therapeutics PTCT:US $ 567.37M 90.6M
Sarepta Therapeutics SRPT:US $ 545.57M 90.6M
Seattle Genetics SGEN:US $ 608.52M 77.23M
Ultragenyx Pharmaceutical RARE:US $ 220.64M 53.4M
Vanda Pharmaceuticals VNDA:US $ 88.4M 2.34M
Vertex Pharmaceuticals VRTX:US $ 2556.2M 376M
YTE INCY:US $ 926.67M 40.51M